[1]
Imran, A.; Shehzad, M.T.; Shah, S.J.A.; Al Adhami, T.; Laws, M.; Rahman, K.M.; Alharthy, R.D.; Khan, I.A.; Shafiq, Z.; Iqbal, J. Development and exploration of novel substituted thiosemicarbazones as inhibitors of aldose reductase via in vitro analysis and computational study. Sci. Rep., 2022, 12, 1-14.
[2]
Mahmood, A.; Villinger, A.; Iqbal, J. Therapeutic potentials and structure-activity relationship of 1, 3-benzodioxole N-carbamothioyl carboxamide derivatives as selective and potent antagonists of P2X4 and P2X7 receptors. Eur. J. Med. Chem., 2022, 114491.
[3]
Imran, A.; Shehzad, M.T.; Shah, S.J.A.; Laws, M.; Al-Adhami, T.; Rahman, K.M.; Khan, I.A.; Shafiq, Z.; Iqbal, J. Development, Molecular Docking, and In Silico ADME Evaluation of Selective ALR2 Inhibitors for the Treatment of Diabetic Complications via Suppression of the Polyol Pathway. ACS Omega, 2022, 7, 26425-26436.
Related Journals
Current Pharmaceutical Design
Current Topics in Medicinal Chemistry
Current Respiratory Medicine Reviews
Infectious Disorders - Drug Targets
Endocrine, Metabolic & Immune Disorders - Drug Targets
Anti-Infective Agents
Coronaviruses
Recent Advances in Inflammation & Allergy Drug Discovery
Current Probiotics
